Ciclosporin in Autoimmune Diseases: 1st International Symposium, Basle, March 18–20, 1985

Preface to CyA Proceedings.- 1. Autoimmunity and Ciclosporin (CyA).- Prevailing Theories in Autoimmune Disorders.- Genetic Role in Autoimmunity.- The Mechanism of Action of Ciclosporin: A Continuing Puzzle.- Contrasting Effects of Ciclosporin on Humoral and Cell-mediated Immunity in Patients with Autoimmune Diseases.- Pharmacokinetics and Interactions of Ciclosporin.- Side Effects and Safety of Sandimmun® in Long-term Treatment of Transplant Patients.- Ciclosporin-associated Nephropathy.- Ciclosporin in Autoimmune Diseases — Side Effects (with Emphasis on Renal Dysfunction) and Recommendations for Use.- Clinical Effects and Renal Side Effects in Patients with Autoimmune Diseases Treated with Ciclosporin (CyA).- 2. Multiple Sclerosis — Myasthenia Gravis — Polymyositis.- The Use of Ciclosporin (CyA) in Multiple Sclerosis — Trial Design and Tolerance.- The Effect of Ciclosporin versus Azathioprine on the Course of Multiple Sclerosis; Design of a Long-term Follow-up Study and Side Effects.- Ciclosporin in the Treatment of Myasthenia Gravis: Preliminary Results from a Pilot Study.- Ciclosporin in Myasthenia Gravis.- Ciclosporin in the Treatment of Polymyositis/Idiopathic Cardiomyopathy.- 3. Diabetes Mellitus Type I.- Type I Diabetes Mellitus: Rationale for Immune Intervention.- Effects of Ciclosporin on Insulin Secretion in Recent Onset Type I Diabetes Mellitus.- Ciclosporin in Insulin-dependent Diabetes Mellitus: Design of Controlled Studies.- 4. Uveitis and Behçet’s Disease.- Effectiveness of Ciclosporin on Sight-threatening Endogenous Uveitis.- Treatment of Noninfectious Inflammatory Disorders of the Eye with Ciclosporin.- Ciclosporin (CyA) in the Treatment of Retinal Vasculitis.- Ciclosporin Treatment of Autoimmune Inflammatory Disorders of the Eye.- Treatment of Ocular Involvement in Behçet’s Disease with Ciclosporin A (Preliminary Report).- Preliminary Results of a Randomized Prospective Study on Treatment of Posterior Uveitis with Ciclosporin or Prednisolone.- Ciclosporin in Idiopathic Posterior Uveitis; Interim Report of a Randomized Double-masked Study.- Ciclosporin (CyA) Versus Conventional Therapy in Behçet’s Disease. Preliminary Observations of a Masked Study.- A Double-masked Study of Ciclosporin Treatment in Behçet’s Disease.- 5. Primary Biliary Cirrhosis — Crohn’s Disease.- Primary Biliary Cirrhosis.- Effect of Ciclosporin (CyA) on Suppressor Cell Function in Patients with Primary Biliary Cirrhosis.- Treatment of Primary Biliary Cirrhosis with Ciclosporin (CyA), Pilot Study.- Ciclosporin Therapy in Primary Biliary Cirrhosis (PBC): A Pilot Study in 10 Patients.- Ciclosporin (CyA) in Primary Biliary Cirrhosis (PBC). A Multicentre, Double-blind, Placebo-controlled Long-term Therapeutic Study. The Study Design.- Ciclosporin for Crohn’s Disease.- Controlled Study of Ciclosporin versus Corticosteroids in Acute Crohn’s Disease: Methodology and Early Findings.- 6. Sarcoidosis — Dermatology.- Ciclosporin (CyA) in the Treatment of Pulmonary Sarcoidosis.- Ciclosporin (CyA) as an Alternative to Steroids in the Treatment of Sarcoidosis and Cryptogenic Interstitial Lung Diseases.- Ciclosporin in the Treatment of Progressive Systemic Sclerosis.- Ciclosporin Inhibits the Effector Function of the T Effector Cell of Delayed Type Hypersensitivity.- Treatment of Pemphigus with Ciclosporin.- Treatment of Bullous Dermatoses with Ciclosporin (CyA).- Ciclosporin (CyA) in Pemphigus and Bullous Pemphigoid.- 7. Endocrine Ophthalmopathy.- Endocrine Ophthalmopathy.- Ciclosporin in the Treatment of Graves’ Ophthalmopathy.- Treatment of Graves’ Ophthalmopathy with Ciclosporin.- A Pilot Study of Ciclosporin in Endocrine Ophthalmopathy.- Ciclosporin Treatment in Severe Graves’ Ophthalmopathy.- 8. Hematology.- Ciclosporin (CyA) as Primary Treatment for Severe Acute Aplastic Anaemia.- Ciclosporin for Therapy of Severe Aplastic Anemia (SAA) and Pure Red Cell Aplasia (PRCA).- Experience with Ciclosporin (CyA) in the Management of Pure Red-Cell Aplasia (PRCA) and Aplastic Anemia (AA).- Ciclosporin in Idiopathic Thrombocytopenic Purpura and Other “Auto-Immune” Cytopenias.- Ciclosporin (CyA) and Intravenous Immunoglobulin (i.V. IgG) in Chronic Immune Thrombocytopenic Purpura (ITP) in Childhood: A Clinical and Immunological Study (Progress Report).- Ciclosporin (CyA) in the Treatment of Autoimmune Blood Disorders.- 9. Rheumatoid Arthritis.- Rheumatoid Arthritis.- Ciclosporin in Rheumatoid Arthritis. Open Trials with Different Dosages.- A Pilot Study of CyA in Patients with Rheumatoid Arthritis (RA).- Low Dose Ciclosporin A and Prednisone — a Step in the Direction of Selective Immunosuppression in Rheumatoid Arthritis Refractory to Treatment (6-Month Follow-Up).- Ciclosporin in Rheumatoid Arthritis — Preliminary Results.- Ciclosporin Treatment in Rheumatoid Arthritis: A Preliminary Report of a Multicentre Placebo-Controlled Double-Blind Study.- Ciclosporin versus Azathioprine in Rheumatoid Arthritis.- Preliminary Observations from a Comparison of Ciclosporin and Azathioprine in Rheumatoid Arthritis.- 10. Glomerulonephritis and Systemic Lupus Erythematosus.- Ciclosporin in Glomerulonephritis — A Pilot Study.- Use of Ciclosporin in Idiopathic Corticoresistant or Cortico-dependent Nephrotic Syndrome (Minimal Change Glomerulopathy and Focal-Segmental Hyalinosis).- Ciclosporin (CyA) in Steroid-insensitive Nephrotic Syndrome in Durban, South Africa.- Ciclosporin Treatment of Idiopathic Nephrotic Syndrome in Children (Minimal Change Disease and Focal Segmental Glomerulosclerosis).- What can NZB/W Mice Teach us about the Treatment of SLE with Ciclosporin?.- Combined Ciclosporin-Steroid Treatment of Systemic Lupus Erythematosus.- Ciclosporin (CyA) and Therapeutic Plasma Exchange in Steroid Resistant SLE.- Possible Beneficial Effect of Ciclosporin in Some Cases of Severe Systemic Lupus Erythematosus.- Open Therapeutic Trial of Ciclosporin in Systemic Lupus Erythematosus. Preliminary Results in 4 Patients.- The Effects of Ciclosporin in Twelve Patients with Severe Systemic Lupus.- Ciclosporin and Autoimmune Disease — an Overview.- Concluding Impressions.